Table 1.
Baseline clinical characteristics of the study participants with and without AF.
| Control | AF | p Value | |
|---|---|---|---|
| Number | 42 | 92 | |
| Male, % | 15 (35.71) | 50 (54.35) | 0.062 |
| HTN, % | 24 (57.14) | 49 (53.26) | 0.712 |
| DM, % | 5 (11.90) | 25 (27.17) | 0.073 |
| CAD, % | 0 (0.00) | 7 (7.61) | 0.098 |
| Smoking, % | 9 (21.43) | 15 (16.30) | 0.476 |
| Drinking, % | 10 (23.81) | 14 (15.22) | 0.235 |
| Age, years | 61.52 ± 9.83 | 65.00 ± 9.88 | 0.061 |
| BMI, kg/m2 | 25.99 ± 3.40 | 26.07 ± 3.60 | 0.918 |
| WBC, ×109/L | 5.90 ± 1.17 | 5.95 ± 1.49 | 0.883 |
| HGB, g/L | 129.28 ± 9.44 | 138.87 ± 17.74 | 0.002 ** |
| PLT, ×109/L | 224.56 ± 40.10 | 204.10 ± 60.54 | 0.173 |
| TC, mmol/L | 4.36 ± 1.06 | 4.06 ± 0.88 | 0.101 |
| TG, mmol/L | 0.95 (0.77, 1.89) | 1.19 (0.92, 1.49) | 0.257 |
| AST, U/L | 17.40 ± 6.67 | 19.86 ± 6.29 | 0.053 |
| ALT, U/L | 13.90 (10.40, 19.30) | 17.00 (13.00, 23.00) | 0.015 * |
| sCr, μmol/L | 65.39 ± 15.41 | 70.57 ± 14.49 | 0.076 |
| cTNI, ng/mL | 0.00 (0.00, 0.00) | 0.00 (0.00,0.01) | 0.266 |
Data are presented as number (%), mean ± SD and median (quartile). ALT, alanine aminotransfease; AST, aspartate aminotransferase; BMI, body mass index; CAD, coronary artery disease; cTNI, cardiac troponin I; DM, diabetes mellitus; HGB, hemoglobin; HTN, hypertension; PLT, platelet; sCr, serum creatinine; TC, total cholesterol; TG, triglyceride; WBC: white blood cell. *, p < 0.05; **, p < 0.01.